Severe hypophosphataemic osteomalacia with primary hyperparathyroidism
Osteomalacia is rare in primary hyperparathyroidism. Characteristically, the serum calcium concentration is normal in primary hyperparathyroidism complicated by vitamin-D-deficient osteomalacia but hypercalcaemia develops quickly after administration of vitamin D.1 2 We have studied a patient with hypercalcaemic primary hyperparathyroidism who presented with hypophosphataemic osteomalacia. Vitamin D treatment produced a rise in serum inorganic phosphate concentration associated with bone healing but no consistent change in serum calcium concentration.
Case report
The patient, a 48-year-old married woman with no previous illness, presented in 1973 with an eight-month history of diffuse and severe bone pains, weakness and muscle wasting, and difficulty in walking. She was unable to stand erect from the sitting position. Pressure applied to her ribcage produced spontaneous severe pain. Skeletal x-ray films showed multiple rib fractures but no obvious subperiosteal erosion. Bone histology showed severe osteomalacia with osteoid 29 % total trabecular bone volume (equivalent to 85 % bone matrix). Plasma concentrations were: calcium 3 2 mmol/l (12-8 mg/100 ml), inorganic phosphate 0 5 mmol/l (1-5 mg/100 ml), creatinine 60 ,tmol/l (07 mg/100 ml), magnesium 0-76 mmol/l (1-8 mg/100 ,ul), alkaline phosphatase 20 KA units, parathyroid hormone 1 9 ng/ml (normal up to 1-0 ng/ml), and 25-hydroxy vitamin D 33 nmol/l (13 ng/ml) (normal 13-88 nmol/l; 5-35 ng/ml). A 24-hour collection of urine contained hydroxyproline 596 ltmol/l (7-8 mg/100 ml), calcium 3-02 mmol/l (12 mg/100 ml), and inorganic phosphate 11-5 mmol/l (36 mg/ 100 ml). Dietary vitamin D intake was normal. A jejunal biopsy specimen and barium studies of the small bowel were normal. Hyperparathyroidism with osteomalacia was diagnosed. She refused neck exploration.
Oral ergocalciferol was started at 50 000 IU/day and gradually increased to 200 000 IU/day. Bone pain persisted for several months but gradually decreased, while walking capacity and muscle power improved. Clinical recovery was complete after 12 months and the treatment stopped. She was seen intermittently during 1975 and then lost to follow-up until October 1977. She then complained of muscle weakness and difficulty in walking but no bone pain. She was persuaded to undergo parathyroid surgery, and an adenoma was removed (Mr J S Waters). Muscle strength returned quickly postoperatively, and she remained well.
The figure shows the changes in plasma concentrations and bone osteoid content. At presentation plasma concentration of parathyroid hormone and 
Treatment of unidentified viper bites
In the tropics many people die from snakebites, and all snakebites, although many produce no signs of systemic poisoning, must be considered as potentially life-threatening.' Specific antivenom is effective treatment, but I believe that it is overused and too often given unnecessarily early. Most authorities suggest that antivenom should be used when there are signs of systemic poisoning-coagulation or neurological disorders.' 2 Traditionally at this hospital patients bitten by snakes were seen by nurses and virtually all given subcutaneous antivenom automatically. We thought that most of these patients did not need antivenom, and so in August 1978 we introduced selective use of the antivenom, and I report our experience.
Patients, methods, and results
Eighteen patients (16 males, 2 females, aged 12-45) presented between August 1978 and November 1979. All were questioned, examined, and had a test for clotting time using 2 ml of venous blood in dry, clean glass tubes. The test result was considered negative if the blood clotted within 10 minutes. All patients bitten within 12 hours of arrival at the hospital and all those with severe local reaction or signs of systemic poisoning were admitted and had their clotting time repeated after 4-6 and 12 hours. Those without signs of systemic poisoning were treated symptomatically and observed closely. Those with neurological disorders or clotting defects were given antivenom intravenously-20 ml Pasteur Institute's anti-Bitis-Echis-Najaserum in 1 litre of normal saline over 1-2 hours. If normal clotting was not re-established this was repeated.
All but one of the 18 had swelling around the site of the bite, which was always painful. (The remaining one had fang marks as evidence of a definite bite.) Some had enlarged tender lymph nodes, none had visible tissue necrosis, and in 17 the bite was on the legs (one had been bitten on the hand). Ten patients described the snake, but only one brought the dead snake with him. Patients arrived at the hospital between one hour and three days after the bite, and 11 had had some treatment before coming. The treatment given had no effect as far as we could tell in all but one case, where an incision made by a local healer had caused severe prolonged bleeding because of a clotting defect. Sixteen patients were admitted, none developed neurological disorders, four had clotting defects on arrival, and of the other 12 none displayed clotting defects. The four patients with clotting defects came to hospital more than 12 hours after being bitten (one three days after), but all eventually responded well to treatment (details in 
